Insulin-like growth factor I receptor-1 mediated IGF-1R activation induces proliferation, epithelial-mesenchymal transition (EMT), metastasis, drug resistance, and tumor recurrence (Li et al., 2017). This evidence concerns the gene IGF1R and neoplasm.